Future studies should adopt a standardized dosing protocol to minimize confounding and ensure interpretability
GLP-1 medications like Ozempic, Wegovy, and Mounjaro increase urinary sodium excretion, suppress thirst signals, and cause GI symptoms (nausea, vomiting, diarrhea) that deplete fluids and minerals
injection), active ingredient (semaglutide vs
Transitioning to synthetic HGH may be required for patients with confirmed severe pituitary dysfunction not responding to optimized Sermorelin protocols
Obesity Medication and the Role of Lifestyle Interventions Delivered by RDNs
Coverage for anti-obesity medications varies, and Medicare Part D formularies have historically excluded many weight loss drugs, though policy changes are expanding access to GLP-1 agonists